Search clinical trials for: 0.3 mg GSK2330672
Total 13904 results
-
GlaxoSmithKlineCompleted
-
Sichuan Haisco Pharmaceutical Group Co., LtdThe First Hospital of Jilin UniversityCompletedHealthy Elderly SubjectsChina
-
MedImmune LLCAstraZenecaTerminatedLupus Erythematosus, SystemicUnited States, Mexico, Peru, South Africa, Canada
-
CelgeneCompleted
-
H. Lundbeck A/SCompleted
-
Acceleron Pharma, Inc., a wholly-owned subsidiary...RecruitingHypertension, PulmonaryUnited States, Belgium, France, Germany, Israel, Italy, Spain, Sweden, United Kingdom, Poland, Canada
-
Kowa Company, Ltd.Completed
-
University of Texas Southwestern Medical CenterUS Department of Veterans AffairsCompletedRectal CancerUnited States
-
Sichuan Haisco Pharmaceutical Group Co., LtdCompleted
-
Kwang Dong Pharmaceutical co., ltd.Completed
-
GlaxoSmithKlineCompletedCholestasisUnited Kingdom
-
AsclepiX Therapeutics, Inc.TerminatedNeovascular Age-Related Macular Degeneration (nAMD)United States
-
AsclepiX Therapeutics, Inc.TerminatedDiabetic Macular Edema (DME)United States
-
ShaperonCompletedCOVID19 PneumoniaRomania
-
AllerganCompletedLong-Term Safety of Bimatoprost Ophthalmic Solution in Patients With Glaucoma or Ocular HypertensionOcular Hypertension | GlaucomaSpain, France, Belgium, Israel, United Kingdom, Poland, Italy, Czechia, Germany, Hungary
-
GlaxoSmithKlineCompleted
-
Atox Bio LtdTerminatedAcute Kidney Injury | Peritonitis | Necrotizing Soft Tissue InfectionUnited States, France
-
Kowa Company, Ltd.Completed
-
Auris Medical AGCompleted
-
ShaperonRecruiting
-
Sunstar AmericasCompletedPeriodontal Diseases | Alveolar Bone LossUnited States
-
Autoimmune Technologies, LLCCompleted
-
University of RostockCompletedObservation of Neuromuscular Block | Complication of Ventilation TherapyGermany
-
Amorepacific CorporationCompleted
-
Atox Bio LtdBiomedical Advanced Research and Development AuthorityCompletedNecrotizing Fasciitis | Necrotizing Soft Tissue Infections | Fournier's GangreneUnited States, France
-
GlaxoSmithKlineCompletedDiabetes Mellitus, Type 2United States
-
PfizerTerminatedMacular Degeneration | Age Related Macular Degeneration (AMD) | Choroidal Neovascularization (CNV)Canada, Belgium, United Kingdom, France, Poland, Spain, Turkey, Czech Republic, Italy, Greece, Germany, Austria, Portugal, Denmark, Finland
-
Instituto Tecnologico y de Estudios Superiores...Tecnologico de MonterreyCompleted
-
NovartisCompletedAge Related Macular DegenerationSwitzerland
-
Alcon ResearchWithdrawn
-
Assiut UniversityCompletedIntraoperative ComplicationsEgypt
-
Teva Branded Pharmaceutical Products R&D, Inc.CompletedRelapsing Remitting Multiple Sclerosis
-
BioMarin PharmaceuticalCompletedPhenylketonuriaUnited States
-
Aristotle University Of ThessalonikiEugonia IVF Unit, Athens, GreeceUnknown
-
Cardiox CorporationWithdrawn
-
E-nitiate Biopharmaceuticals (Hangzhou) Co., Ltd.Recruiting
-
IRCCS Azienda Ospedaliero-Universitaria di BolognaUnknown
-
Rhodes Pharmaceuticals, L.P.Purdue Pharma LPCompletedAttention Deficit Hyperactivity Disorder (ADHD)United States
-
ShireCompletedGastroesophageal Reflux DiseaseUnited States, Czechia, Germany, Latvia, Poland, Romania
-
University of FaisalabadNot yet recruiting
-
Biomedisyn CorporationYale UniversityCompleted
-
GlaxoSmithKlineCompletedCholestasisUnited States, Australia, France, Spain, Germany, Canada, Japan, United Kingdom, Italy, Poland
-
Merck Sharp & Dohme LLCCompleted
-
University of ReadingCompletedVasodilationUnited Kingdom
-
Georgetown UniversityCompletedPeripheral Vascular DiseaseUnited States
-
ShaperonCompletedAtopic DermatitisKorea, Republic of
-
Andrew J. Armstrong, MDCompletedProstate CancerUnited States
-
Auris Medical, Inc.TerminatedHearing Loss, Idiopathic Sudden SensorineuralUnited States, Korea, Republic of, Canada
-
Rhodes Pharmaceuticals, L.P.Purdue Pharma, CanadaCompleted
-
Rhodes Pharmaceuticals, L.P.Purdue Pharma LPCompleted